Fabry disease, an X-linked lysosomal storage disorder due to alpha-galactosidase A deficiency, leads to an accumulation of globotriaosylceramide resulting in a multisystemic disorder. The initial manifestations of the disease are not specific, leading to a delayed diagnosis. We report a patient in whom the diagnosis was obtained by family screening and the confrontation of clinical signs. We also present a 4 year follow-up under enzyme replacement therapy (agalsidase β, 1 mg/kg/14 days).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S0248-8663(10)70018-7 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!